Lysate from H1299 cells transiently transfected with wild--type p53 was separated by superose 6 gel chromatography, and p53 and CCTε subunit expression assessed in fractions 1--22 by western blotting. p53 was immunoprecipitated from fractions 9--12 with DO--1 antibody, then analyzed for CCTα and p53 expression by western blotting. Protein expression levels were detected by western blot with CCTε and Actin antibody.
The graph shows the mean +/--SEM from three independent experiments. (D) Invasion of parental (wild--type p53 expressing) RPE cells in which p53 and/or CCT α+ε were depleted using siRNA targeting p53 and CCTα+ε was tested as in (C). The graph shows the mean +/--SEM from four independent experiments and * indicates p<0.05.
SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Cell culture and reagents H1299, HCT116, A2780, U2OS and MCF--7 cells were obtained from ATCC and cultured in DMEM supplemented with 10% FBS and 1% Glutamine at 37°C and 5% CO2. Infinity™
Telomerase--immortalised RPE cells were obtained from Clontech and cultured in DMEM/F12 HAM supplemented with 10% FBS, 1.6% Sodium bicarbonate and 1%
Glutamine at 37°C and 5% CO2. Stable H1299 cells expressing pCB6 and 273H were described previously (Muller et al., 2009 ). H1299 cells expressing Δ39 were generated by selecting transfected cells 24 hours after transfection in 500ng/ml G418 for 10 days.
Stable doxycycline--inducible monoclonal Tet--on H1299 cells expressing wild--type p53
or 273H p53 were generated as described previously (Nakano et al., 2000) .
Cells were treated with 5μM of the Mdm2 inhibitor Nutlin--3a (Cayman Chemical), with 10μM of the proteasome inhibitor MG132 (Sigma) and 200g/μl of cycloheximide (Sigma). 1mM and 0.2mM of nucleotides ATP (Sigma), ADP (Sigma) respectively and Proteinase K as indicated (Sigma) were used for the in vitro reactions. To inhibit the chaperone activity of Hsp70/Hsc70, 40μM of the inhibitor VER--155008 (Tocris Bioscience) which is able to bind to the ATPase site of both Hsc/p70 described previously (Massey et al., 2010) .
Plasmids, sequences and transfections
Expression plasmids for p53 wild--type, p53--273H, p53--175H, p53--175 22/23, p53--22/23, p53Δ43, p53Δ327, p53Δ347, p53Δ370, p53ΔI, p53ΔII, p53ΔIII, p53ΔIV, p53ΔV, p53Δ28--40, p53Δ41--49, p53Δ39 have been described previously Marston et al., 1994; Muller et al., 2009 ). Plasmid pCHDM1A--wild--type Mdm2 has been described previously (Chen et al., 1995) . pTRE--tight expression vectors were obtained from Clontech and p53 was cloned into this vector using the BamH1 and EcoR1 restriction sites. pG13--luciferase construct, containing generic p53 response elements Transfection of p53 constructs was performed using GeneJuice (Novagen) according to the manufacturers' instructions and the expression levels were assessed 24 hours later.
Alignment of p53 sequences of different species was performed using BOXSHADE 3.21.
Mass spectrometry
For the mass spectrometry analysis, three 15cm plates of H1299 cells were used per ammonium bicarbonate (AB) for 20 minutes at 56°C), alkylated (55mM iodacetamide, 50mM AB for 1 hour at room temperature) and digested (modified porcine trypsin (Promega) for 90 minutes at 37°C). Digested material was extracted from gel pieces with 0.1% trifluoroacetic acid, 5% MeCN (Sigma), and concentrated to 20 μl volume. The digest was subject to separation on an Ultimate 3000 nanoLC (Dionex, Sunnyvale, CA).
Acquired tandem mass spectra were exported from Analyst using the script Mascot.dll 1.6b23 (matrix Science, London, UK). Protein identification was obtained using Mascot 2.3.02 software (Matrix Science). Scaffold (version Scaffold_3.1.2, Proteome Software Inc., Portland, OR) was used to validate MS/MS based peptide and protein identifications. Peptide identifications were accepted if they could be established at greater than 95.0% probability as specified by the Peptide Prophet algorithm, resulting in a peptide false discovery rate (FDR) of 1.0% (Keller et al., 2002) . Protein identifications were accepted if they could be established at greater than 99.0%
probability and contained at least 4 identified peptides. Protein probabilities were assigned by the Protein Prophet algorithm (Nesvizhskii et al., 2003) .
Immunoprecipitation, western blot and protein stability analysis
For immunoblotting, cells were collected by centrifugation, washed with cold PBS and lysed in NP--40 lysis buffer (50mM Tris--HCl pH=7, 150mM NaCl, 1mM EDTA and 1% NP--40 supplemented with a complete protease inhibitor cocktail). 50µg total proteins were separated in SDS--PAGE and transferred onto nitrocellulose membranes. Membranes were blocked in 5% milk and 0.2% tween20 in TBS and western blot analysis was carried out according to the method described previously (Kubbutat et al., 1999) . The following monoclonal and polyclonal antibodies were used to detect all human proteins:
anti--p53 DO--1 (Vojtesek et al., 1992) , anti--p53 1801 (Banks et al., 1986) , anti--p53 CM--1 To measure protein stability, cells were treated for the indicated times with 50μg/ml of cycloheximide (Sigma). Cells were harvested and processed for western blot as described above. Actin was used as a loading control, and bands were quantified using Li--Cor software by normalizing to the band intensity of the sample without cycloheximide treatment. Results are expressed as a percentage of intensity relative to the untreated sample
In vitro translation and biochemical methods
In vitro translation of p53 was performed in TNT ® SP6 couple reticulocyte lysate system (Promega) using the constructs PGEM--wild--type p53, Δ2--13 and Δ4--13 as a template.
5µl of each reaction was used to validate the expression of p53 and CCT subunits. To test the binding of endogenous CCTε and in vitro translated p53, 20μl of reticulocyte lysate were used.
CCT conformational changes and p53 folding were carried out as described (Frydman and Hartl, 1996; Meyer et al., 2003) . In vitro translated p53 was incubated for 90 minutes at 30°C in a reaction buffer (50mM Tris HCl pH 7.5, 150 mM NaCl, 5mM MgCl2, 0.1 mM PMSF, 0.5% NP--40 and 10% Glycerol) with 200ng of CCT purified protein. The CCT--p53 complexes were incubated for 30 minutes at 30°C with 1mM of ATP alone or in presence of a γ--phosphate analogue AIFx (5mM Al(NO3)3 + 30mM NaF) (Sigma) which replaces Pi released in the ATPase reaction and traps CCT complex in a close conformation. Proteolytic digestion of the complex was performed with addition of 0.5μg/ml of proteinase K (Sigma) for 10 minutes at 25°C. Reaction was stopped by addition of 10mM of PMSF.
In vitro CCT/p53 binding assays
CCT was purified from bovine testis as described (Cuellar et al., 2008) . The CCT--p53 complexes were formed by denaturing human p53 protein in 6M guanidine hydrochloride and subsequent 100--fold dilution in buffer (50 mM Tris pH 7.4, 500 mM NaCl, 5 mM MgCl2, 2 mM DTT) containing 2 mM purified CCT (1:10 chaperonin:p53 molar ratio) for 30 minutes at 30°C. Aliquots were then subjected to native electrophoresis using 4% (w/v) acrylamide gels run at 90--100 V for 4--5 hours. The chaperonin band, clearly separated in the gel from the unbound p53 protein, was stained with Bio--Safe Coomassie (BIO--RAD) and subsequently excised, dehydrated at 95°C for 5 minutes and rehydrated with denaturing loading electrophoresis buffer.
Samples were boiled for 5 minutes and loaded onto an 8% (w/v) SDS--PAGE. After the electrophoresis was performed, the gels were blotted electrophoretically for 50 minutes to a 0.2mm nitrocellulose membrane (BIO--RAD) using a Trans--Blot SD Transfer Cell (BIO--RAD). The nitrocellulose membrane was subsequently blocked by washing the membrane with WB buffer (3% skimmed milk, 0.05% Tween--20 in PBS buffer) for one hour at room temperature. The membrane was then incubated with a 1:1000 dilution of mouse monoclonal anti--p53 antibody followed by a 1:5000 dilution of a sheep anti--mouse horseradish peroxidase--conjugated secondary antibody (GE Healthcare).
Immunoblots were developed with the ECL Plus chemiluminescence reagent (GE Healthcare) and visualized with a Storm 860 PhosphoImager (Amersham Biosciences).
Electron microscopy and image processing
Samples (either CCT or CCT:p53) were applied onto carbon--coated copper grids previously glow--discharged and stained with 2% uranyl acetate. Micrographs were taken under minimal dose conditions on Kodak S0--163 film, in a JEOL JEM 1200EXII microscope with a tungsten filament operated at 100 kV and at 60000 magnification.
Micrographs were digitalized in a Zeiss SCAI scanner with a sampling window corresponding to 7Å/pixel for all specimens. Individual particles were manually selected using XMIPP software package (Sorzano et al., 2004) . Image classification was performed using a free--pattern maximum--likelihood multi--reference protocol (Scheres et al., 2005) , which gave rise to homogeneous populations, which were then averaged to generate a final two--dimensional average image.
Gel chromatography
Analytical gel filtrations of lysates were performed using Superose 6 10/300 GL (GE Healthcare) with a following running buffer: 50mM Tris--HCl pH 7.0, 250mM NaCl and 1mM DTT. Experiments were conducted with a flow rate of 0.5ml/minute and an injection volume of 500µl. The molecular masses of separated fractions were deduced from calibration curve of Superose 6 10/300 GL column. Fractions of 1ml were collected and precipitated by incubation at 4°C for 1 hour with 10% tricloroacetic acid (TCA).
Precipitates were rinsed twice with pure acetone, dried for 2 minutes at 90°C, resuspended in Laemmli buffer and boiled for 5 minutes.
Ubiquitination in cells
HCT116 cells expressing endogenous wild--type p53 were transfected with siRNA against CCTα and ε subunits for 48 hours. pGFP--HisUb plasmid was transfected for 24
hours before harvest and expression of the GFP construct was verified by fluorescence microscopy. Cells were treated with 10μM of MG132 for 4 hours, harvested in UBA buffer (6M Guanidinium HCl, 300mM NaCl, 50mM phosphate pH 8.0, 100μg/ml N--ethylmaleimide (NEM)) and sonicated twice for 10 seconds at 40% amplitude. Cell lysates were incubated overnight with His--tag matrix Dynabeads (Invitrogen), then washed once with UBA buffer, UBB buffer (1:1 UBA:UBC) and once with UBC (300mM NaCl, 50mM phosphate pH 8.0, 100μg/ml NEM). Beads were resuspended in Laemmli buffer and ubiquitin protein precipitates separated by SDS--PAGE and visualized by western blot with the p53 antibody DO--1.
mRNA gene expression analysis
RNA was prepared using an extraction column according to the manufacturer's instructions (Qiagen). Complementary DNA was generated using first--strand cDNA kit 
In--Cell western TM assay
The conformation of p53 in cells was determined in an In--cell western assay according to the manufacturers' instructions (Li--Cor). 5000 cells were seeded in 96 CellBIND surface plates (Corning) and transfected for 24 hours with the p53 constructs as indicated. Cells were fixed in 4% para--formaldehyde (Sigma) in PBS for 10 minutes at 4°C and blocked for 1 hour at RT with blocking buffer (PBS pH=7, 0.4% TRITON X--100(Sigma) and 1% BSA (Sigma). Primary antibodies (p53 polyclonal (Santa Cruz) and 1620 (Calbiochem)) were incubated for 2 hours at RT followed by 3 washes with blocking buffer. IREDye secondary antibodies 800CW or 640CW (Li--Cor) were incubated for 45 minutes at RT and cells were scanned in ODDYSEY CLx infrared system and the intensity of the fluorescence in cells was quantified with Image Studio Software 2.0 (Li--Cor).
Invasion and migration assays
Matrigel assays were performed as previously described (Caswell et al., 2008) . Matrigel (BD Biosciences) was supplemented with 25µg/ml of fibronectin (FN, Sigma) and polymerized at 37°C for 45 minutes in transwell inserts (Corning). The plates were inverted and 2.5x10 4 H1299 cells or 3.5x10 4 RPE cells in 100µl were seeded on the base.
The inserts were placed in serum free medium and topped with medium containing 10% FCS and a mixture of chemo attractants: 25ng/ml EGF and 10ng/ml HGF (Sigma).
The remaining cells were re--plated and used to check protein expression by western blot analysis. Migrating cells were stained after 3 days with Calcein (Invitrogen) and visualized using an inverted confocal microscope (Leica2) in serial sections at 10µm intervals. Quantification of invading cells was determined using ImageJ software, in which intensity was measured using the area calculator plugin software. The percentage invasion was determined by measuring the total intensity of all slides beyond 30--50µm compared to the total intensity of all slides.
Invasion in organotypic assays was performed as previously described (Edward et al., 2005) . In brief, rat--tail collagen was isolated and allowed to contract in the presence of telomerase--immortalized fibroblasts to generate organotypic plugs. Next, 5x10 4 H1299 cells stably expressing p53 constructs or H1299 cells transfected with the indicated p53 constructs were seeded on top of these plugs for 16 hours. Plugs and cells were then
